ALUR: a phase 3 study of alectinib versus chemotherapy in previously treated ALK plus non-small cell lung cancer (NSCLC)

被引：4

作者：

Wolf, J. ^{[1
]}

Oh, I-J. ^{[2
]}

Mazieres, J. ^{[3
]}

de Castro, J. ^{[4
]}

Revil, C. ^{[5
]}

Kotb, A. ^{[6
]}

Johansdottir, H. ^{[7
]}

Zeaiter, A. ^{[5
]}

Novello, S. ^{[8
]}

机构：

[1] Univ Hosp Cologne, Internal Med, Cologne, Germany

[2] Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Jeonnam, South Korea

[3] CHU Toulouse, Hop Larrey, Thorac Oncol, Toulouse, France

[4] Hosp Univ La Paz, Med Oncol, Madrid, Spain

[5] F Hoffmann La Roche Ltd, Med Oncol, Basel, Switzerland

[6] F Hoffmann La Roche Ltd, Med Affairs, Basel, Switzerland

[7] F Hoffmann La Roche Ltd, PDO, Basel, Switzerland

[8] Univ Turin, Oncol, Orbassano, Italy

来源：

关键词：

D O I：

10.1093/annonc/mdw383.90

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1290TiP

引用

页数：1